Review 1 : "Use of Indomethacin for mild and moderate Covid -19 patients. A Randomized Control Trial"
This preprint evaluates the clinical efficacy of indomethacin for mild and moderate COVID-19, and finds that patients treated with indomethacin experienced oxygen desaturation less frequently with more rapid recovery times. Reviewers deemed the results compelling and reliable.
Created on
Feb 01, 2022
Published on
Feb 01, 2022
Cite As
Sukhatme, V. (2022). Review 1 : “Use of Indomethacin for mild and moderate Covid -19 patients. A Randomized Control Trial.” Rapid Reviews Infectious Diseases. https://doi.org/10.1162/2e3983f5.ded0ac7a